This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Atrialfibrillation (AFib) is a common heart rhythm disorder characterized by an irregular and often rapid heartbeat. This condition can lead to various complications, including stroke and heartfailure, making it essential to understand its causes, symptoms, and AFib treatment options.
(MedPage Today) -- The efficacy of catheter ablation for heartfailure (HF) patients with atrialfibrillation (Afib or AF) hinged on the phenotype of disease, researchers reported based on a meta-analysis. Compared with conventional rate or rhythm.
A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrialfibrillation (or AFib)—an irregular, fast heartbeat that is associated with stroke and heartfailure.
Atrialfibrillation, or AFib, is a fast and irregular heart rhythm that, left untreated, can lead to blood clots, stroke and heartfailure. It's the most common type of arrhythmia, a potentially serious condition in which the heart beats too quickly, too slowly or in an irregular pattern.
An international consensus statement on how to treat atrialfibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.
The collaboration, according to a written statement issued by the company, aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrialfibrillation procedures. Our mission to combat complex heart rhythm diseases relies on optimizing interoperability.
Atrialfibrillation catheter ablation (AFCA) improved clinical outcomes compared with medical treatment alone, and early AFCA was associated with better outcomes than late AFCA, particularly decreased risk of heartfailure (HF) hospitalization and atrialfibrillation (AFib) recurrence.
A BMJ study out of Denmark provided alarming new insights into atrialfibrillation’s impact on patients’ future cardiovascular health, while highlighting the need to improve post-AFibheartfailure and stroke prevention. Danish people who didn’t have AFib at baseline (45-95yrs, 48yr avg, 51.7% in 2011-2022.
At the forefront of PowerPlugs is AFib Detection , a PowerPlug that discreetly monitors your heart rhythm every night to detect signs of AtrialFibrillation (AFib). Ultrahuman Ring AIR is the first smart ring in the world to offer AFib detection.
History of prior heartfailure (HF) was found to influence prognostic implications of atrialfibrillation (AFib) in patients hospitalized for HF, with permutations of prior HF, prior AFib and AFib as presenting rhythm differentiating outcome.
tim.hodson Thu, 03/27/2025 - 12:18 March 27, 2025 Abbott recently announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrialfibrillation (AFib). Today, approximately 8 million Europeans over the age of 65 are living with AFib, a number expected to double over the next 30 years.
It is estimated that more than 12 million people in the United States will have AtrialFibrillation, or AFib in 2030. It is one of the most commonly diagnosed heart conditions and is characterized by an irregular heartbeat or rhythm, known as arrhythmia.
milla1cf Wed, 12/13/2023 - 10:24 December 13, 2023 — A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrialfibrillation (or AFib)—an irregular, fast heartbeat that is associated with stroke and heartfailure.
Catheter Ablation for AtrialFibrillation (AFib) in heartfailure is now a class I indication for patients with heartfailure. Evidence supports the relationship between obesity and the incidence and recurrence of Afib.
September is National AtrialFibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Physicians have a crucial role in recognizing, diagnosing, and managing AFib to prevent its potentially life-threatening complications.
September is National AtrialFibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Physicians have a crucial role in recognizing, diagnosing, and managing AFib to prevent its potentially life-threatening complications.
Atrialfibrillation often shortened to AFib is an irregular and often rapid heart rhythm that can lead to serious health complications. If you or someone you know is living with AFib, understanding the condition and how to prevent attacks is crucial. What Is AFib? How Do You Know If You Have AFib?
Catheter ablation (CA) for atrialfibrillation (AF) and heartfailure with reduced ejection fraction <40% (HFrEF) is associated with improved outcomes. The patient characteristics, AF effect on quality-of-life questionnaire (AFEQT), and ablation strategies performed remains uncertain in those with and without HFrEF.
Performing additional catheter ablations targeting diseased myocardium along with the standard approach of pulmonary vein isolation (PVI) to treat persistent atrialfibrillation (AFib) did not reduce the recurrence of AFib at one year, based on findings from the SUPPRESS-AF trial presented at ESC Congress 2024 in London.
Abstract Introduction Atrialfibrillation (Afib) is a prevalent chronic arrhythmia associated with severe complications, including stroke, heartfailure, and increased mortality. Results/Observation Current Afib detection methods, such as electrocardiography, have limitations in sensitivity and specificity.
Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrialfibrillation (AFib).
This middle-aged patient has a remote history of cardiac surgery as a young child for a "heart murmur". Her Apple Watch suddenly told her that she is in atrialfibrillation. Exam was completely normal except for an irregular heart rate. I focus my comment on a few additional aspects regarding new AFib.
Research covered topics such as outcomes for pediatric subcutaneous ICD implantation; procedural success rates and risk factors associated with catheter ablation for atrial tachyarrhythmias; comparing echocardiographic guidance during left atrial appendage occlusion (LAAO); and atrialfibrillation (AFib) ablation in patients with heartfailure with (..)
While the holidays themselves can’t cause a heart attack , certain things people do during the hectic, festive season may stress their heart health more than they realize. Plus, these stressors can increase the risk of heart attack, stroke or retention of extra fluid and heartfailure , explains Dr. Tarditi.
It’s well known that heart disease is the U.S.’s Heart Disease in 2050 – The AHA warned of massive heart disease increases by 2050, spanning CVD (+60%), diabetes (+100%), obesity (+70%), hypertension (+44%), heartfailure (+66%), and stroke (+100%). trillion, representing 4.6% If applied across the U.S.,
A swimmer, hiker, and martial artist, you’d never guess 64-year-old Trisha McLaughlin struggled with an irregular heartbeat, congestive heartfailure, and has undergone a number of heart procedures.
Introduction:Anticoagulation (AC) is the mainstay of thromboprophylaxis for stroke prevention in atrialfibrillation (AF) and is recommended. PSM components were age, gender, race, PPI use, anti-platelets, hypertension, coronary artery disease, heartfailure, COPD, and CKD.
In July 2023 Eko Health announced a partnership with Japanese Life Sciences company Astellas Pharma to develop a non-invasive device Digital Therapeutics (DTx) solution for heartfailure patients. Fertile Partnerships Ongoing research partnerships have driven much of recent developments seen in the market.
Prognostic impact of severe tricuspid regurgitation (TR) in patients with atrial functional mitral regurgitation (AFMR). The primary endpoint was a composite of heartfailure hospitalization and all-cause mortality. The secondary endpoint was all-cause mortality. in severe AFMR.
She was known to have a history of poorly controlled COPD, AFib, and multivessel coronary disease. There is bradycardic AtrialFibrillation with broad ST-depression in most leads and perceptible ST-elevation in aVR. She was switched to an alternative rate-limiting drug for the AtrialFibrillation.
Continue reading to learn more about this procedure, its significance in treating atrialfibrillation, and what to expect during treatment. What is AtrialFibrillation? Before diving into electrical cardioversion, we should understand atrialfibrillation (AF). What Is Cardioversion?
Adenosine is only unsafe in atrialfibrillation with WPW , which presents with a very rapid rate, polymorphic QRS, and some very short RR intervals] Bedside echo showed poor LV fct. But we just decided that we DON'T want a conversion to sinus until we can ascertain absence of thrombus in the atrial appendage!
(Harvard University Heart Letter) A clinical polygenic risk score test for diseases ranging from atrialfibrillation (AFib) to breast cancer was piloted by scientists. American College of Cardiology Journal) Are you thinking of stopping your antiplatelet medication too soon after angioplasty? Reconsider your position.
She previously had Atrialfibrillation with LBBB. This shows atrialfibrillation. The fact that the response is regular proves that the atrialfibrillation is NOT conducting. When atrial fib conducts, the ventricular rate must always be irregular. There is a regular, slow response.
OSA disproportionately affects the 92 million Americans living with cardiovascular disease (CVD), often goes undiagnosed (1) , and doubles the risk for heartfailure and other serious cardiovascular conditions. Peerbridge Health continues to innovate by compounding clinical utility in one simple device," said Andrea Natale, M.D.,
She also has a hx of paroxysmal atrialfibrillation and is on oral anticoagulant treatment. Slow VT below the detection rate of the ICD lead to worsening heartfailure and low stroke volume. Post conversion of VT the patient had low output cardiac failure and became unstable and hypoperfused.
Medical history: History of Ischemic Heart Disease History of Congestive HeartFailure Diabetes Mellitus requiring treatment with insulin Pre-operative serum creatinine >2 mg/dL He had this ECG recorded: What do you think? This was interpreted as "AtrialFibrillation". See Ken's interpretation below.
The American College of Cardiology (ACC) and the American Heart Association (AHA) recently published new guidelines for the diagnosis and management of patients with atrialfibrillation (AF). Given the data, the Class of Recommendation for this population of patients has also been upgraded.
NT-proBNP values less than 300 pg/ml have a 99% negative predictive value for excluding congestive heartfailure. A cutoff of 1200 pg/ml for patients with a normal eGFR is very specific for heartfailure. Troponin I was 0.054 ng/mL NT-ProBNP was 8316 (0-900 pg/mL). "
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content